| Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ... Nature 582 (7811), 289-293, 2020 | 4354 | 2020 |
| Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease W Dai, B Zhang, XM Jiang, H Su, J Li, Y Zhao, X Xie, Z Jin, J Peng, F Liu, ... Science 368 (6497), 1331-1335, 2020 | 1496 | 2020 |
| Structural basis for molecular recognition at serotonin receptors C Wang, Y Jiang, J Ma, H Wu, D Wacker, V Katritch, GW Han, W Liu, ... Science 340 (6132), 610-614, 2013 | 617 | 2013 |
| Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients H Su, S Yao, W Zhao, M Li, J Liu, W Shang, H Xie, C Ke, H Hu, M Gao, ... Acta Pharmacologica Sinica 41 (9), 1167-1177, 2020 | 415 | 2020 |
| Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy Z Tan, L Xiao, M Tang, F Bai, J Li, L Li, F Shi, N Li, Y Li, Q Du, J Lu, ... Theranostics 8 (9), 2329, 2018 | 208 | 2018 |
| Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry WH Guo, X Qi, X Yu, Y Liu, CI Chung, F Bai, X Lin, D Lu, L Wang, J Chen, ... Nature communications 11 (1), 4268, 2020 | 171 | 2020 |
| NEET proteins: a new link between iron metabolism, reactive oxygen species, and cancer R Mittler, M Darash-Yahana, YS Sohn, F Bai, L Song, IZ Cabantchik, ... Antioxidants & redox signaling 30 (8), 1083-1095, 2019 | 166 | 2019 |
| Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro H Su, S Yao, W Zhao, M Li, J Liu, WJ Shang, H Xie, C Ke, M Gao, K Yu, ... BioRxiv, 2020.04. 13.038687, 2020 | 159 | 2020 |
| Redox-dependent gating of VDAC by mitoNEET CH Lipper, JT Stofleth, F Bai, YS Sohn, S Roy, R Mittler, R Nechushtai, ... Proceedings of the National Academy of Sciences 116 (40), 19924-19929, 2019 | 112 | 2019 |
| Free energy landscape for the binding process of Huperzine A to acetylcholinesterase F Bai, Y Xu, J Chen, Q Liu, J Gu, X Wang, J Ma, H Li, JN Onuchic, H Jiang Proceedings of the National Academy of Sciences 110 (11), 4273-4278, 2013 | 100 | 2013 |
| The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer F Bai, F Morcos, YS Sohn, M Darash-Yahana, CO Rezende, CH Lipper, ... Proceedings of the National Academy of Sciences 112 (12), 3698-3703, 2015 | 93 | 2015 |
| Elucidating the druggable interface of protein− protein interactions using fragment docking and coevolutionary analysis F Bai, F Morcos, RR Cheng, H Jiang, JN Onuchic Proceedings of the National Academy of Sciences 113 (50), E8051-E8058, 2016 | 89 | 2016 |
| Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters M Darash-Yahana, Y Pozniak, M Lu, YS Sohn, O Karmi, S Tamir, F Bai, ... Proceedings of the National Academy of Sciences 113 (39), 10890-10895, 2016 | 85 | 2016 |
| Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19 Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ... | 76 | 2020 |
| Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway Q Li, JX Tan, Y He, F Bai, SW Li, YW Hou, LS Ji, YT Gao, X Zhang, ... International journal of biological sciences 18 (4), 1594, 2022 | 70 | 2022 |
| Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β KH Yim, TL Prince, S Qu, F Bai, PA Jennings, JN Onuchic, ... Proceedings of the National Academy of Sciences 113 (33), E4801-E4809, 2016 | 70 | 2016 |
| A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors P Ren, W Shang, W Yin, H Ge, L Wang, X Zhang, B Li, H Li, Y Xu, EH Xu, ... Acta Pharmacologica Sinica 43 (2), 483-493, 2022 | 69 | 2022 |
| Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP 72 as an upstream target XY Zeng, H Wang, F Bai, X Zhou, SP Li, LP Ren, RQ Sun, CCL Xue, ... British journal of pharmacology 172 (17), 4303-4318, 2015 | 69 | 2015 |
| DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs F Li, Q Hu, X Zhang, R Sun, Z Liu, S Wu, S Tian, X Ma, Z Dai, X Yang, ... Nature communications 13 (1), 7133, 2022 | 67 | 2022 |
| Cyndi: a multi-objective evolution algorithm based method for bioactive molecular conformational generation X Liu, F Bai, S Ouyang, X Wang, H Li, H Jiang BMC bioinformatics 10, 1-14, 2009 | 62 | 2009 |
Jose OnuchicCTBP Rice UniversityPotvrđena adresa e-pošte na rice.edu
